Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ST 630

Known as: ST-630 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
26,26,26,27,27,27-Hexafluoro-1,25-dihydroxyvitamin D<sub>3</sub> (ST-630) is a newly developed agent to maintain the levels of… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1998
1998
1. Kidney mitochondrial 24-hydroxylase cytochrome P450 (CYP24) catalyses sequential hydroxylation at both C-24 and C-23 positions… Expand
Is this relevant?
1997
1997
慢性腎不全に伴う二次性副甲状腺機能亢進症に対する新規の活性型ビタミンD3製剤falecalcitriol (ST-630) の有効性・安全性および至適投与量を二重盲検法による群間比較にて検討した. 最終全般改善度の判定は開始時に対するHS-PTH… Expand
Is this relevant?
1994
1994
The binding properties of [3H]1,25-dihydroxyvitamin D3 (1,25(OH)2D3) to 1,25(OH)2D3 receptor in mouse osteoblastic MC3T3-E1 cells… Expand
Is this relevant?
1994
1994
We investigated the metabolism of 26,26,26,27,27,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 (26,27-F6-1,25(OH)2D3, ST-630) and… Expand
Is this relevant?